Cellective Therapeutics' Series A Round

Cellective Therapeutics raised a round of funding on September 17, 2004.

Cellective was developing several new pharmaceuticals treating B Cell related cancer and immune diseases. The technology is based on research by Founder Tom Tedder, Chairman of Immunology at Duke Univ…

Articles about Cellective Therapeutics' Series A Round: